eppendorf 5417r centrifuge  (Eppendorf AG)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94
    Name:
    Centrifuge Performance Plan
    Description:
    Unique cross over Centrifuge 5430 and 5430 R combine the best features of a microcentrifuge small footprint and multipurpose centrifuge versatility in one instrument These centrifuges spin rotors for Eppendorf tubes and PCR strips as you would expect from any microcentrifuge But that s not all In a compact size Centrifuge 5430 and 5430 R also accommodate rotors for microplates and 15 50 mL conical tubes Now the rotor program has been expanded with additional Eppendorf QuickLock rotors This includes 48 place rotors 1 5 2 0 mL a 16 place rotor for Eppendorf Tubes 5 0 mL and a swing bucket rotor 24 × 1 5 2 0 mL With their unmatched versatility Centrifuge 5430 and Centrifuge 5430 R are the flagship products among the Eppendorf microcentrifuge portfolio
    Catalog Number:
    0082020003
    Price:
    None
    Category:
    Centrifuge 5430 5430 R Centrifuges Centrifugation
    Buy from Supplier


    Structured Review

    Eppendorf AG eppendorf 5417r centrifuge
    Unique cross over Centrifuge 5430 and 5430 R combine the best features of a microcentrifuge small footprint and multipurpose centrifuge versatility in one instrument These centrifuges spin rotors for Eppendorf tubes and PCR strips as you would expect from any microcentrifuge But that s not all In a compact size Centrifuge 5430 and 5430 R also accommodate rotors for microplates and 15 50 mL conical tubes Now the rotor program has been expanded with additional Eppendorf QuickLock rotors This includes 48 place rotors 1 5 2 0 mL a 16 place rotor for Eppendorf Tubes 5 0 mL and a swing bucket rotor 24 × 1 5 2 0 mL With their unmatched versatility Centrifuge 5430 and Centrifuge 5430 R are the flagship products among the Eppendorf microcentrifuge portfolio
    https://www.bioz.com/result/eppendorf 5417r centrifuge/product/Eppendorf AG
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    eppendorf 5417r centrifuge - by Bioz Stars, 2021-09
    94/100 stars

    Images

    Related Articles

    other:

    Article Title: A cell atlas of chromatin accessibility across 25 adult human tissues
    Article Snippet: After resuspension in permeabilization buffer, nuclei were rotated at 4 °C for 5 minutes before being pelleted again with a swinging bucket centrifuge (500 x g, 5 min, 4°C; 5920R, Eppendorf).

    Article Title: Effect of Oral Administration with Lactobacillus plantarum CAM6 Strain on Sows during Gestation-Lactation and the Derived Impact on Their Progeny Performance
    Article Snippet: To obtain blood, serum tubes with vacutainer red cap without anticoagulant (Vacutainer®; BD, Franklin Lakes, New Jersey, USA) were used, which were centrifuged at 3000 rpm (Eppendorf centrifuge AG, New York, USA) for 15 min at room temperature.

    Article Title: A cell atlas of chromatin accessibility across 25 adult human tissues
    Article Snippet: Nuclei were rotated at 4 °C for 5 minutes before being pelleted again with a swinging bucket centrifuge (500 x g, 5 min, 4°C; 5920R, Eppendorf).

    Article Title: Microscopic Methods for Analysis of Macrophage Induced Tunneling Nanotubes
    Article Snippet: Eppendorf centrifuge 58 10 R. 10 cm tissue culture treated dishes.

    Article Title: Genetic Diversity of Recent Infectious Bursal Disease Viruses Isolated From Vaccinated Poultry Flocks in Malaysia
    Article Snippet: The homogenate was followed by freeze-thawing three times, and it was centrifuged at 4,000 rpm (Eppendorf Centrifuge 5,810 R) at 4°C for 5 min.

    Article Title: Surface-bound reactive oxygen species generating nanozymes for selective antibacterial action
    Article Snippet: Into phosphate buffer solution (PBS, at pH 7.4) were successively added dispersion of a nanoparticle dispersion in PBS (to an expected final particle mass concentration of 8, 16, or 32 μg/mL) and AA solution in PBS (to a final AA concentration of 60 μM); The final volumes of the resulting dispersions were kept constant at 1 mL.

    Article Title: Insights from the first genome assembly of Onion (Allium cepa)
    Article Snippet: After incubating the samples for 3 minutes at RT, they were centrifuged at 10,000 rpm in an Eppendorf centrifuge for 3 minutes, followed by transfer of the water-phase to a clean tube.

    Centrifugation:

    Article Title: Differential Effects of Antiseptic Mouth Rinses on SARS-CoV-2 Infectivity In Vitro
    Article Snippet: .. To assess the effect of mouth rinses on the viruses, mouth rinse-treated SARS-CoV-2 viruses were concentrated by centrifugation at 14,000 rpm in a centrifuge (Eppendorf) at 4 °C for 2 h as described previously [ ]. ..

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    Eppendorf AG serial benchtop centrifugation
    Patients with unstable CAD have a decreased concentration of uEVs. EVs were isolated from 6 ml of urine using a <t>benchtop</t> centrifugation protocol. (A) Images of uEVs were taken using an FEI Tecnai 12 Transmission Electron Microscope (Magnification: 43,000× and 135,000×). (B) The total concentration of particles (5-200nm) was determined by NTA using the NanoSight NS300. (C) R Studio analysis was performed to compare the size distribution and concentration of the NTA data. (D) The EV (Bodipy + ) concentration was determined by flow cytometry using the ImageStream™X Mark II. (E) The percentage of CD63 + Bodipy + EVs was also determined. (F) Images of EVs stained with Bodipy and positive for the fluorescent antibodies CD63 and CD45 were obtained using the ImageStream™X Flow Cytometer. Statistical analysis was performed using nonparametric Mann Whitney U tests where *p
    Serial Benchtop Centrifugation, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/serial benchtop centrifugation/product/Eppendorf AG
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    serial benchtop centrifugation - by Bioz Stars, 2021-09
    86/100 stars
      Buy from Supplier

    97
    Eppendorf AG nanoemulsion centrifugation
    <t>Nanoemulsion</t> droplet size evaluated during storage for ClFPh-CHA-loaded (gray bars) and blank nanoemulsions (white bars).
    Nanoemulsion Centrifugation, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nanoemulsion centrifugation/product/Eppendorf AG
    Average 97 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    nanoemulsion centrifugation - by Bioz Stars, 2021-09
    97/100 stars
      Buy from Supplier

    93
    Eppendorf AG eppendorf centrifuge 5417r
    <t>Nanoemulsion</t> droplet size evaluated during storage for ClFPh-CHA-loaded (gray bars) and blank nanoemulsions (white bars).
    Eppendorf Centrifuge 5417r, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eppendorf centrifuge 5417r/product/Eppendorf AG
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    eppendorf centrifuge 5417r - by Bioz Stars, 2021-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    Patients with unstable CAD have a decreased concentration of uEVs. EVs were isolated from 6 ml of urine using a benchtop centrifugation protocol. (A) Images of uEVs were taken using an FEI Tecnai 12 Transmission Electron Microscope (Magnification: 43,000× and 135,000×). (B) The total concentration of particles (5-200nm) was determined by NTA using the NanoSight NS300. (C) R Studio analysis was performed to compare the size distribution and concentration of the NTA data. (D) The EV (Bodipy + ) concentration was determined by flow cytometry using the ImageStream™X Mark II. (E) The percentage of CD63 + Bodipy + EVs was also determined. (F) Images of EVs stained with Bodipy and positive for the fluorescent antibodies CD63 and CD45 were obtained using the ImageStream™X Flow Cytometer. Statistical analysis was performed using nonparametric Mann Whitney U tests where *p

    Journal: Frontiers in Immunology

    Article Title: microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression

    doi: 10.3389/fimmu.2020.576516

    Figure Lengend Snippet: Patients with unstable CAD have a decreased concentration of uEVs. EVs were isolated from 6 ml of urine using a benchtop centrifugation protocol. (A) Images of uEVs were taken using an FEI Tecnai 12 Transmission Electron Microscope (Magnification: 43,000× and 135,000×). (B) The total concentration of particles (5-200nm) was determined by NTA using the NanoSight NS300. (C) R Studio analysis was performed to compare the size distribution and concentration of the NTA data. (D) The EV (Bodipy + ) concentration was determined by flow cytometry using the ImageStream™X Mark II. (E) The percentage of CD63 + Bodipy + EVs was also determined. (F) Images of EVs stained with Bodipy and positive for the fluorescent antibodies CD63 and CD45 were obtained using the ImageStream™X Flow Cytometer. Statistical analysis was performed using nonparametric Mann Whitney U tests where *p

    Article Snippet: Urinary Extracellular Vesicle Isolation and Characterization EVs were isolated from urine via serial benchtop centrifugation (Eppendorf Centrifuge 5417R) at 4°C.

    Techniques: Concentration Assay, Isolation, Centrifugation, Transmission Assay, Microscopy, Flow Cytometry, Staining, MANN-WHITNEY

    Nanoemulsion droplet size evaluated during storage for ClFPh-CHA-loaded (gray bars) and blank nanoemulsions (white bars).

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Nanoemulsion droplet size evaluated during storage for ClFPh-CHA-loaded (gray bars) and blank nanoemulsions (white bars).

    Article Snippet: Characterization of samples in terms of preparation particle size distribution (z -average and PDI) was conducted at predetermined intervals after their preparation and compared with the initial values. (d) Determination of Encapsulation Efficiency The encapsulation efficiency (EE%) of compound ClFPh-CHA into nanoemulsion was determined indirectly by the ultrafiltration method according to Equation (1). (1) EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques:

    Dose-dependent effects of ClFPh-CHA on the in vivo growth of MDA-MB-231 cell xenografts. ClFPh-CHA was delivered orally as a nanoemulsion ( a ) or by intraperitoneal injection as a solution ( b ). Control groups in each experiment received vehicle only. Different from control: *** P

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Dose-dependent effects of ClFPh-CHA on the in vivo growth of MDA-MB-231 cell xenografts. ClFPh-CHA was delivered orally as a nanoemulsion ( a ) or by intraperitoneal injection as a solution ( b ). Control groups in each experiment received vehicle only. Different from control: *** P

    Article Snippet: Characterization of samples in terms of preparation particle size distribution (z -average and PDI) was conducted at predetermined intervals after their preparation and compared with the initial values. (d) Determination of Encapsulation Efficiency The encapsulation efficiency (EE%) of compound ClFPh-CHA into nanoemulsion was determined indirectly by the ultrafiltration method according to Equation (1). (1) EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques: In Vivo, Multiple Displacement Amplification, Injection

    Final weights of excised tumors were determined at necropsy for ( a ) mice receiving increasing doses of ClFPh-CHA-loaded nanoemulsion orally and ( b ) mice receiving increasing doses of ClFPh-CHA in solution by intraperitoneal injection (32 days and 38 days of daily treatment for oral and IP administration, respectively). Values were compared to tumor weights of control groups of mice that received vehicle only (CTL). Different from control: * P

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Final weights of excised tumors were determined at necropsy for ( a ) mice receiving increasing doses of ClFPh-CHA-loaded nanoemulsion orally and ( b ) mice receiving increasing doses of ClFPh-CHA in solution by intraperitoneal injection (32 days and 38 days of daily treatment for oral and IP administration, respectively). Values were compared to tumor weights of control groups of mice that received vehicle only (CTL). Different from control: * P

    Article Snippet: Characterization of samples in terms of preparation particle size distribution (z -average and PDI) was conducted at predetermined intervals after their preparation and compared with the initial values. (d) Determination of Encapsulation Efficiency The encapsulation efficiency (EE%) of compound ClFPh-CHA into nanoemulsion was determined indirectly by the ultrafiltration method according to Equation (1). (1) EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques: Mouse Assay, Injection, CTL Assay

    Effect of the number of homogenization cycles on nanoemulsion droplet size (empty circles) and PDI (empty squares).

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Effect of the number of homogenization cycles on nanoemulsion droplet size (empty circles) and PDI (empty squares).

    Article Snippet: Characterization of samples in terms of preparation particle size distribution (z -average and PDI) was conducted at predetermined intervals after their preparation and compared with the initial values. (d) Determination of Encapsulation Efficiency The encapsulation efficiency (EE%) of compound ClFPh-CHA into nanoemulsion was determined indirectly by the ultrafiltration method according to Equation (1). (1) EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques: Homogenization

    Final weights of excised tumors were determined at necropsy for ( a ) mice receiving increasing doses of ClFPh-CHA-loaded nanoemulsion orally and ( b ) mice receiving increasing doses of ClFPh-CHA in solution by intraperitoneal injection (32 days and 38 days of daily treatment for oral and IP administration, respectively). Values were compared to tumor weights of control groups of mice that received vehicle only (CTL). Different from control: * P

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Final weights of excised tumors were determined at necropsy for ( a ) mice receiving increasing doses of ClFPh-CHA-loaded nanoemulsion orally and ( b ) mice receiving increasing doses of ClFPh-CHA in solution by intraperitoneal injection (32 days and 38 days of daily treatment for oral and IP administration, respectively). Values were compared to tumor weights of control groups of mice that received vehicle only (CTL). Different from control: * P

    Article Snippet: EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , (1) The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques: Mouse Assay, Injection, CTL Assay

    Effect of the number of homogenization cycles on nanoemulsion droplet size (empty circles) and PDI (empty squares).

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Effect of the number of homogenization cycles on nanoemulsion droplet size (empty circles) and PDI (empty squares).

    Article Snippet: EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , (1) The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques: Homogenization

    Nanoemulsion droplet size evaluated during storage for ClFPh-CHA-loaded (gray bars) and blank nanoemulsions (white bars).

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Nanoemulsion droplet size evaluated during storage for ClFPh-CHA-loaded (gray bars) and blank nanoemulsions (white bars).

    Article Snippet: EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , (1) The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques:

    Dose-dependent effects of ClFPh-CHA on the in vivo growth of MDA-MB-231 cell xenografts. ClFPh-CHA was delivered orally as a nanoemulsion ( a ) or by intraperitoneal injection as a solution ( b ). Control groups in each experiment received vehicle only. Different from control: *** P

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Dose-dependent effects of ClFPh-CHA on the in vivo growth of MDA-MB-231 cell xenografts. ClFPh-CHA was delivered orally as a nanoemulsion ( a ) or by intraperitoneal injection as a solution ( b ). Control groups in each experiment received vehicle only. Different from control: *** P

    Article Snippet: EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , (1) The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques: In Vivo, Multiple Displacement Amplification, Injection